PHILADELPHIA In response to the growing body of research in the field of cancer prevention, the American Association for Cancer Research (AACR) announces the launch of a major peer-reviewed scientific journal, Cancer Prevention Research, and invites submissions of papers. This important new journal is the first in the world dedicated exclusively to cancer prevention, from preclinical research to clinical trials.
In the past, scientists and interested readers have had to parse cancer prevention articles from many other journals, unable to find the full range of prevention research and opinion in one resource, said Editor-in-Chief Scott M. Lippman, M.D., professor at The University of Texas M. D. Anderson Cancer Center. The richness and scope of our field now parallel those of mainstream oncology and require this new, centralized home for the wide-ranging literature that supports prevention discovery.
The main purpose of Cancer Prevention Research is to build a translational bridge between the basic and clinical sciences in the field of cancer prevention, said Lippman. Articles will cover the preclinical and clinical work of nearly every cancer prevention discipline, from molecular biology to medical oncology, from behavioral science to surgical oncology, from nutritional science to exciting new areas such as infection- and inflammation-related cancer prevention. Cancer Prevention Research also will serve as a forum for perspectives on key public policy issues affecting cancer prevention and will highlight the central role of cancer prevention and early detection in public health, Lippman said.
The emphasis on linking preclinical and clinical research in prevention is unique among scientific journals. The idea to launch Cancer Prevention Research came from the basic, clinical and translational researchers who are AACR members, said AACR President William N. Hait, M.D., Ph.D. On behalf of AACR, I thank Dr. Lippman and his outstanding
'/>"/>
| Contact: Greg Lester greg.lester@aacr.org 267-646-0554 American Association for Cancer Research Source:Eurekalert |